We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Panel of MicroRNAs Differentiates Uncomplicated and Severe Malaria in Children

By LabMedica International staff writers
Posted on 25 Jan 2021
MicroRNAs (miRNAs), which are rapidly released from damaged tissues into the host fluids, constitute a promising biomarker for the prognosis of severe malaria.

MiRNAs comprise a class of about 20 nucleotides-long RNA fragments that block gene expression by attaching to molecules of messenger RNA in a fashion that prevents them from transmitting the protein synthesizing instructions they had received from the DNA. More...
With their capacity to fine-tune protein expression via sequence-specific interactions, miRNAs help regulate cell maintenance and differentiation. In addition to miRNAs playing an essential role in tumor development, dysregulation of certain miRNAs has been associated with many different diseases, such as dementia and cardiovascular conditions.

Investigators at the Barcelona Institute for Global Health (Spain) postulated that miRNA levels in plasma would be expressed differentially among children with severe and uncomplicated malaria due to parasite sequestration in vital organs of severely ill children. A characteristic of severe malaria is the sequestration of Plasmodium falciparum infected red blood cells in vital organs such as the lungs, kidneys, or brain. Resulting organ damage triggers the release of miRNAs into body fluids, including the blood.

To prove their hypothesis, the investigators used advanced sequencing techniques to identify miRNAs released by human brain endothelial cells growing in culture when the cultures were exposed to red blood cells infected by P. falciparum. They then applied next-generation sequencing to evaluate the differential expression of these miRNAs in severe malaria (SM) and in uncomplicated malaria (UM) in children living in Mozambique.

Results revealed that six miRNAs were associated with in vitro P. falciparum cytoadhesion, severity in children, and P. falciparum biomass. The six miRNAs were found to be elevated in children with severe malaria. One of the miRNAs was positively related to the amount of a parasite-derived protein HRP2 (histidine rich protein 2). Previous studies had found that the concentration of HRP2 could be used to quantify growth of the parasite in vitro and to define severe malaria in patients.

"We hypothesized that miRNA levels in plasma would be differently expressed in children with severe and uncomplicated malaria, due to parasite sequestration in vital organs," said senior author Dr. Alfredo Mayor, an associate research professor at the Barcelona Institute for Global Health."Our results indicate that the different pathological events in severe and uncomplicated malaria lead to differential expression of miRNAs in plasma. These miRNAs could be used as prognostic biomarkers of disease, but we need larger studies to validate this."

The malaria microRNA study was published in the February 2021 online edition of the journal Emerging Infectious Diseases.

Related Links:
Barcelona Institute for Global Health


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Pathology

view channel
Image: The new methyl-copying PCR method preserves DNA methylation patterns during amplification (Photo courtesy of Syndex Bio)

Novel mcPCR Technology to Transform Testing of Clinical Samples

DNA methylation is an important biological marker used in the diagnosis and monitoring of many diseases, including cancer. These chemical modifications to DNA influence gene activity and can reveal early... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.